Skip to content
DraconiticResearch
Search Sources API
209,932 studies31 sourcesUpdated 1 h ago

Oncology

5,300 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,302 studies

  1. Protruding Geometry Provides Potential Homing Sites of Circulating Tumor Cells
    Y. Leng, B. Li
    bioRxivPreprintCC BYFull textOncologybioRxiv
  2. Immunotherapy in Liver Transplant Recipients with Advanced Solid Malignancies: A Three-Patient Case Series.
    Belinda Jiao, Charles Vincent Rajadurai, Nissim Benizri +7
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMC
  3. [¹⁷⁷Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
    Carlo Buonerba, Giuseppe Di Lorenzo
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMCDOAJ
  4. Clinicopathologic Predictors of PSMA-PET Detection, Recurrence Pattern, and Biochemical Outcome Following Salvage Radiotherapy After Radical Prostatectomy
    R. Jubril, A. V. Prabhu, O. Ishaq +6
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxivPMC
  5. Optimising cancer immunotherapy and emerging data supporting de-escalation strategies.
    Brindley Hapuarachi, Philippa G Corrie, Rebecca Lee +2
    BMJ oncologyPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  6. Burden, patterns, and challenges of HIV-associated malignancies in Nigeria: a narrative review
    Olugbenga Silas, Chuwang Nyam, Yop Tsok +20
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  7. Endocrine resistance in HR+/HER2− breast cancer: molecular mechanisms and emerging therapeutic strategies
    Tong Shen, Hui Li, Xubin Zhang +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  8. Combined analysis of preoperative circulating tumor cells status and tumor size to guide width of resection margin for solitary hepatocellular carcinoma
    Jiansen Xie, Qijie Luo, Dongdong Huang +12
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  9. Stress-informed parametric shape adaptive patient-specific implant design in computer-assisted jaw reconstruction
    Ankit Nayak, Yu-Xiong Su, Jane Jingya Pu
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  10. Metabolic oncology: clonal selection and the pre-existing origins of cancer resistance
    Cesar A. Perez, Annette R. Khaled
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  11. Prospective evaluation of combination oral S-1 and intravenous cisplatin in cancer patients with severe hepatic dysfunction – a feasibility, safety, and pharmacokinetic study
    Yong Xiang Gwee, Andrea Li Ann Wong, Boon Cher Goh +16
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  12. A solitary brain metastasis from gastroesophageal junction adenocarcinoma 13 years after curative multimodality treatment: a case report and review of the literature
    Sara Di Lorenzo, Pasqualina Giordano, Giuseppe Catapano +6
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  13. A predefined sulphur-handling transcriptional programme is associated with colorectal cancer molecular subtypes
    Shaheryar Shafi, Arslan Hamid, Jiao Yang +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  14. Comparative efficacy of fruquintinib, regorafenib or TAS-102 in patients with KRAS-mutant metastatic colorectal cancer: a systematic review and network meta-analysis
    Yingyu Zhou, Shiqing Zhao, Xiaoyi Zheng +6
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  15. Case Report: A germline SDHB c.268C>T (p.Arg90Ter) variant in a family with very-early-onset colorectal neoplasia
    Chang Liu, Dayang Zhou, Wenjing Xu +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  16. Postoperative ctDNA could potentially spare patients from unnecessary adjuvant therapy in HPV-negative head and neck squamous cell carcinoma: a meta-analysis
    Mohammad Rehan Asad, Alejandra Flores Pusarico, Nidhi Reji +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  17. Psychological flourishing among young and middle-aged postoperative lung cancer patients: a latent profile analysis
    Xiuxiu Wang, Yaxuan Gui, Yingying Sang +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  18. Association of endoscopic and CT response with pathological response after preoperative FLOT-based therapy for gastric and gastroesophageal junction cancer: a retrospective cohort study
    Huseyin Gencer, Gokhan Ucar, Efnan Algın +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  19. Stage-specific miR-188-5p and ER stress markers reflect tumor aggressiveness in prostate cancer
    Hasan Riza Aydin, Ibrahim Sibal, Orhan Semerci +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  20. FLNA Expression in Cancer-Associated Fibroblasts Is Associated with Immunosuppression and Tumor Progression in Colorectal Cancer.
    Qianze Yao, Ningbo Liu, Shilong Li +4
    Journal of CancerPeer-reviewedCC BYFull textOncologyEurope PMC
  21. Real-World Comparative Survival Outcomes of First-Line Serplulimab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer: A Single-Center Retrospective Cohort Study.
    Yuhao Jing, Miao Li, Songxiang Li +4
    Journal of CancerPeer-reviewedCC BYFull textOncologyEurope PMC
  22. P-cadherin Overexpression Induces Partial Epithelial-to-Mesenchymal Transition and Confers Chemoresistance in Dysplastic Oral Epithelial Cells.
    Aaron Suresh Mody, Christine Paulette Neal, Kristen Kim Drinkwater +2
    Journal of CancerPeer-reviewedCC BYFull textOncologyEurope PMC
  23. Cinobufagin induces peroxisome dysfunction through suppression of the peroxisomal biogenesis factor proteins and interferes with lipid metabolism to affect the growth of liver cancer cells
    Jingyi Yang, Wanjun Shao, Congying Yu +4
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  24. Venlafaxine in oncology: supportive-care evidence and emerging preclinical anticancer signals: a systematic review
    Ahmad J. Harahsheh, Zhuldyz Myrzabay, Nazym Askambayeva +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  25. The synergistic potential of combining PD-1/PD-L1 inhibitors with conventional therapies in esophageal squamous cell carcinoma
    Ruyan Li, Zihao Heng, Xi Cheng
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC